# OnCo record paper-conroy-prodige-23-neoadjuvant-folfirinox-rectal-lancet-oncol-2021 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-conroy-prodige-23-neoadjuvant-folfirinox-rectal-lancet-oncol-2021/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-conroy-prodige-23-neoadjuvant-folfirinox-rectal-lancet-oncol-2021" ;
  schema:name "Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23)"@en ;
  schema:description "Six cycles of a three-drug chemotherapy before the usual chemoradiotherapy raised three-year disease-free survival from 69 to 76 percent, and left patients with less nerve damage than giving the chemotherapy afterwards."@en ;
  schema:url <https://onco.cc/key-papers/paper-conroy-prodige-23-neoadjuvant-folfirinox-rectal-lancet-oncol-2021/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/S1470-2045(21)00079-6>, <https://pubmed.ncbi.nlm.nih.gov/33862000/> ;
  onco:tag "colorectal-evidence" ;
  schema:sameAs <https://doi.org/10.1016/S1470-2045(21)00079-6> ;
  schema:datePublished "2021"^^xsd:gYear ;
  schema:author "Conroy T, Bosset JF, Etienne PL, et al." ;
  onco:related <https://onco.cc/key-papers/paper-bahadoer-rapido-short-course-radiotherapy-lancet-oncol-2021/> ;
  onco:cancers <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/rectal-cancer/> ;
  onco:sections <https://onco.cc/fronts/chemotherapy/>, <https://onco.cc/fronts/radiation/> ;
  onco:technologies <https://onco.cc/terms/radiotherapy/>, <https://onco.cc/technologies/imrt-igrt/> ;
  onco:drugs <https://onco.cc/drugs/folfirinox/>, <https://onco.cc/drugs/folfox/>, <https://onco.cc/drugs/capecitabine/>, <https://onco.cc/drugs/oxaliplatin/>, <https://onco.cc/drugs/irinotecan/> ;
  onco:companies <https://onco.cc/companies/unicancer/> ;
  onco:terms <https://onco.cc/terms/total-neoadjuvant-therapy/>, <https://onco.cc/terms/chemoradiation/>, <https://onco.cc/terms/total-mesorectal-excision/> ;
  onco:trials <https://onco.cc/trials/prodige-23/> ;
  onco:people <https://onco.cc/people/thierry-conroy/> ;
  onco:journals <https://onco.cc/journals/lancet-oncology/> .